Prof Dean Ho found that when antiviral drugs molnupiravir and Paxlovid were each combined with the protease-inhibiting drug YH-53, the mix was effective against the Omicron variant of the coronavirus in lab settings.

Read more: https://news.nus.edu.sg/nus-researchers-tap-on-ai-to-improve-effectiveness-of-covid-19-drugs/